Takeshi Suzuki

发表

Synthesis and Pharmacological Evaluation of 5-(4-Biphenyl)-3-methyl-4-phenyl-1,2,4-triazole Derivatives as a Novel Class of Selective Antagonists for the Human Vasopressin V1A Receptor

J. Tsukada, S. Tsukamoto, S. Sakamoto, 2002 .

Synthesis and pharmacological evaluation of 5-(4-biphenyl)-3-methyl-4-phenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human vasopressin V(1A) receptor.

J. Tsukada, S. Tsukamoto, S. Sakamoto, 2002, Journal of medicinal chemistry.

Binding and Signal Transduction Characteristics of the Nonpeptide Vasopressin V1A Receptor-Selective Antagonist YM218 in Cultured Rat Mesangial Cells

K. Momose, M. Shibasaki, J. Tsukada, 2006, Pharmacology.

Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist.

M. Shibasaki, J. Tsukada, W. Uchida, 2005, Vascular pharmacology.

Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.

M. Shibasaki, J. Tsukada, W. Uchida, 2005, Pharmacological research.

Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy.

M. Shibasaki, J. Tsukada, A. Tahara, 2007, Vascular pharmacology.

Discovery of 4,5-diphenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human V(1A) receptor.

S. Tsukamoto, S. Sakamoto, A. Kakefuda, 2002, Bioorganic & medicinal chemistry.

Effects of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells.

K. Momose, M. Shibasaki, J. Tsukada, 2006, European journal of pharmacology.

VASOPRESSIN STIMULATES THE PRODUCTION OF EXTRACELLULAR MATRIX BY CULTURED RAT MESANGIAL CELLS

M. Shibasaki, J. Tsukada, A. Tahara, 2008, Clinical and experimental pharmacology & physiology.

Effect of vasopressin on type IV collagen production in human mesangial cells

M. Shibasaki, J. Tsukada, A. Tahara, 2008, Regulatory Peptides.

Synthesis and biological evaluation of 3-biphenyl-4-yl-4-phenyl-4H-1,2,4-triazoles as novel glycine transporter 1 inhibitors.

A. Kohara, S. Tsukamoto, S. Sakamoto, 2011, Journal of medicinal chemistry.

Atropisomeric 4-phenyl-4H-1,2,4-triazoles as selective glycine transporter 1 inhibitors.

Shuichi Sakamoto, Junji Miyata, Takashi Sugane, 2013, Journal of medicinal chemistry.

Synthesis and biological activity of novel 4,4-difluorobenzazepine derivatives as non-peptide antagonists of the arginine vasopressin V1A receptor.

M. Orita, J. Tsukada, A. Kakefuda, 2006, Bioorganic & medicinal chemistry.